Gordana Vunjak-Novakovic

Gordana Vunjak-Novakovic is a Serbian American biomedical engineer. She is the Mikati Foundation Professor of Biomedical Engineering and Professor of Medical Sciences at Columbia University, where she directs the Laboratory for Stem Cells and Tissue Engineering. Her group focuses on engineering human tissues for regenerative medicine, stem cell research and modeling of disease.^[1]^[2] Together with her team she has published over 310 engineering papers, 58 book chapters and three books on tissue engineering.^[3] According to Google Scholar, her papers have been cited over 28,000 times, and she has an h-index of 95 as of November 1, 2015.^[4] Vunkak-Novakovic has also given 325 invited lectures across the world and is named as co-inventor on 72 licensed, issued and pending patents. Building on these patents she co-founded two biotech companies, epiBone and TARA Biosystems. In addition, she is a frequent advisor to the federal government on tissue engineering and regenerative medicine.

Biography

Vunjak received her B.S., M.S., and Ph.D. in chemical engineering from the University of Belgrade, in Belgrade, Serbia. After her postgraduate study in Germany, she returned as a faculty to the University of Belgrade in its Chemical Engineering Department. She was a Fulbright Fellow at Massachusetts Institute of Technology’s Harvard-MIT Division of Health Sciences and Technology from 1986 to 1987 and held joint appointments as Research Scientists at the Whitaker College of Health Sciences and Technology at MIT (1993-1998) and as Adjunct Professor in the Department of Biomedical Engineering at Tufts University (1994-2004). In 1998 she became a full time Principal Research Scientist with the Harvard-MIT Division of Health Science and Technology at MIT, where she collaborated, among others, with renowned biomedical engineer Robert S. Langer. In 2005, she accepted a position as Full Professor with the Department of Biomedical Engineering at Columbia University.

Research

Prof. Vunjak-Novakovic’s numerous scholarly accomplishments have substantially impacted the field of tissue engineering in specific and the field of biomedical engineering in general.^[1] The focus of her research is on engineering functional human tissues, by an integrated use of stem cells, biomaterial scaffolds and bioreactors, which are culture systems designed to regulate and stimulate tissue development. In her work she has laid the theoretical and experimental foundation for the development of new biomaterials and scaffold architecture to regenerate tissue. For example, a series of 5 papers on bioreactors, seeding of polymer scaffolds for cartilage tissue engineering, cultivation parameters, and tissue construct characterization, published in 1998 and 1999 have been cited over a 2,000 times.^[5]^[6]^[7]^[8]^[9] Building on these efforts, Prof. Vunjak-Novakovic continued to perform complex cell biological studies that address fundamental problems such as the growth and differentiation of stem cells for functional skeletal and cardiac mechanics, the growth of mammalian cells in microgravity environment, and the role of chondrocytes in cartilage tissue biomechanics. In ways not achieved by any other research team, Prof. Vunjak-Novakovic’s group has succeeded to control cell growth, metabolism and function of tissue constructs. This has garnered her highest praise and recognition of the scientific community. She is now starting to translate this foundation into clinical applications that promise to profoundly influence the way patient are treated and medicine is practiced.

Recognition

In 2007, Vunjak-Novakovic became the first woman engineer to receive the distinction of giving the Director’s Lecture at the National Institute of Health. In 2008, she was inducted into the Women in Technology International Hall of Fame, and in 2009, she was elected to the New York Academy of Sciences. One year later she received the Clemson Award of the Society of Biomaterials “for significant contributions to the literature on the science or technology of biomaterials.” In 2012 she was elected to the National Academy of Engineering "for bioreactor systems and modeling approaches for tissue engineering and regenerative medicine," becoming the first woman at Columbia to ever earn that prestigious distinction. Two years later this was followed by the elections to the Institute of Medicine (IOM) of the National Academies,^[10] and the National Academy of Inventors.^[11] In addition, Vunjak-Novakovic is an elected fellow of the American Institute for Medical and Biological Engineering, a fellow of the Biomedical Engineering Society, a fellow of AAAS, and a founding fellow of TERMIS. She is a member of the Academia Europaea, Serbian Academy of Sciences and Arts, the Women in Technology International Hall of Fame, and one of Foreign Policy 100 leading global thinkers for 2014. The list of recognitions also includes important plenary lectures, such as the Key Opinion Leader speaker at the Life Sciences Summit 2011, Distinguished Speaker at the 2010 Annual Meeting of the Biomedical Engineering Society, the 2010 Keynote at the Stem Cell Bioengineering Conference, and the 2011 Plenary Lecture at the UK National Stem Cell Network Conference. As her research has made substantial breakthroughs in recent years, her work has also captured the imagination of the general public and was featured in the New York Times,^[1] Scientific American,^[12] Forbes Magazine,^[13] National Public Radio (NPR),^[14] and the BBC.^[15]^[16]

References

External links

This article is issued from Wikipedia - version of the Monday, May 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.